Cargando…

Serious Infection Rates Among Patients with Select Autoimmune Conditions: A Claims-Based Retrospective Cohort Study from Taiwan and the USA

INTRODUCTION: Serious infections are an important concern for patients with autoimmune conditions. We sought to estimate serious infection rates among patients with select autoimmune conditions relative to the general population in Taiwan and the USA. METHODS: This retrospective cohort study estimat...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Wen-Nan, Chuo, Ching-Yi, Lin, Ching-Heng, Chen, Yi-Ming, Lin, Wei-Szu, Tuckwell, Katie, Jones, Nicholas S., Galanter, Joshua, Lindsay, Lisa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10011274/
https://www.ncbi.nlm.nih.gov/pubmed/36572758
http://dx.doi.org/10.1007/s40744-022-00525-x
_version_ 1784906353568907264
author Huang, Wen-Nan
Chuo, Ching-Yi
Lin, Ching-Heng
Chen, Yi-Ming
Lin, Wei-Szu
Tuckwell, Katie
Jones, Nicholas S.
Galanter, Joshua
Lindsay, Lisa
author_facet Huang, Wen-Nan
Chuo, Ching-Yi
Lin, Ching-Heng
Chen, Yi-Ming
Lin, Wei-Szu
Tuckwell, Katie
Jones, Nicholas S.
Galanter, Joshua
Lindsay, Lisa
author_sort Huang, Wen-Nan
collection PubMed
description INTRODUCTION: Serious infections are an important concern for patients with autoimmune conditions. We sought to estimate serious infection rates among patients with select autoimmune conditions relative to the general population in Taiwan and the USA. METHODS: This retrospective cohort study estimated setting-specific standardized serious infection incidence rates and ratios among patients with systemic lupus erythematosus, including extra-renal lupus and lupus nephritis, rheumatoid arthritis and primary membranous nephropathy, compared with the general population using insurance claims for hospitalizations between 2000 and 2013. Multivariable Cox proportional hazard models were used to estimate adjusted hazard ratios for serious infections, adjusting for age, sex, index year, prior serious infection, comorbidities and medications. RESULTS: In Taiwan, serious infection rates were 22.7, 28.7, 70.6, 43.4 and 215.3 per 1000 person-years among the general population and among cohorts of patients with primary membranous nephropathy, rheumatoid arthritis, extra-renal lupus and lupus nephritis, respectively. In the USA, serious infection rates were 2.6, 9.0, 15.6, 21.0 and 63.3 per 1000 person-years among the general population and among cohorts of patients with primary membranous nephropathy, rheumatoid arthritis, extra-renal lupus and lupus nephritis, respectively. Patients had significantly higher serious infection rates than the general population in both settings, largely driven by bacterial, respiratory, urinary tract and opportunistic infections. Patients with lupus nephritis had the highest burden of serious infections relative to the general population, with 7- to 25-fold higher adjusted hazard ratios in Taiwan and the USA, respectively. CONCLUSION: This study identified a significant excess serious infection burden among patients with targeted autoimmune conditions compared with the general populations in Taiwan and the USA. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s40744-022-00525-x.
format Online
Article
Text
id pubmed-10011274
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer Healthcare
record_format MEDLINE/PubMed
spelling pubmed-100112742023-03-15 Serious Infection Rates Among Patients with Select Autoimmune Conditions: A Claims-Based Retrospective Cohort Study from Taiwan and the USA Huang, Wen-Nan Chuo, Ching-Yi Lin, Ching-Heng Chen, Yi-Ming Lin, Wei-Szu Tuckwell, Katie Jones, Nicholas S. Galanter, Joshua Lindsay, Lisa Rheumatol Ther Original Research INTRODUCTION: Serious infections are an important concern for patients with autoimmune conditions. We sought to estimate serious infection rates among patients with select autoimmune conditions relative to the general population in Taiwan and the USA. METHODS: This retrospective cohort study estimated setting-specific standardized serious infection incidence rates and ratios among patients with systemic lupus erythematosus, including extra-renal lupus and lupus nephritis, rheumatoid arthritis and primary membranous nephropathy, compared with the general population using insurance claims for hospitalizations between 2000 and 2013. Multivariable Cox proportional hazard models were used to estimate adjusted hazard ratios for serious infections, adjusting for age, sex, index year, prior serious infection, comorbidities and medications. RESULTS: In Taiwan, serious infection rates were 22.7, 28.7, 70.6, 43.4 and 215.3 per 1000 person-years among the general population and among cohorts of patients with primary membranous nephropathy, rheumatoid arthritis, extra-renal lupus and lupus nephritis, respectively. In the USA, serious infection rates were 2.6, 9.0, 15.6, 21.0 and 63.3 per 1000 person-years among the general population and among cohorts of patients with primary membranous nephropathy, rheumatoid arthritis, extra-renal lupus and lupus nephritis, respectively. Patients had significantly higher serious infection rates than the general population in both settings, largely driven by bacterial, respiratory, urinary tract and opportunistic infections. Patients with lupus nephritis had the highest burden of serious infections relative to the general population, with 7- to 25-fold higher adjusted hazard ratios in Taiwan and the USA, respectively. CONCLUSION: This study identified a significant excess serious infection burden among patients with targeted autoimmune conditions compared with the general populations in Taiwan and the USA. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s40744-022-00525-x. Springer Healthcare 2022-12-26 /pmc/articles/PMC10011274/ /pubmed/36572758 http://dx.doi.org/10.1007/s40744-022-00525-x Text en © The Author(s) 2022 https://creativecommons.org/licenses/by-nc/4.0/Open AccessThis article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Original Research
Huang, Wen-Nan
Chuo, Ching-Yi
Lin, Ching-Heng
Chen, Yi-Ming
Lin, Wei-Szu
Tuckwell, Katie
Jones, Nicholas S.
Galanter, Joshua
Lindsay, Lisa
Serious Infection Rates Among Patients with Select Autoimmune Conditions: A Claims-Based Retrospective Cohort Study from Taiwan and the USA
title Serious Infection Rates Among Patients with Select Autoimmune Conditions: A Claims-Based Retrospective Cohort Study from Taiwan and the USA
title_full Serious Infection Rates Among Patients with Select Autoimmune Conditions: A Claims-Based Retrospective Cohort Study from Taiwan and the USA
title_fullStr Serious Infection Rates Among Patients with Select Autoimmune Conditions: A Claims-Based Retrospective Cohort Study from Taiwan and the USA
title_full_unstemmed Serious Infection Rates Among Patients with Select Autoimmune Conditions: A Claims-Based Retrospective Cohort Study from Taiwan and the USA
title_short Serious Infection Rates Among Patients with Select Autoimmune Conditions: A Claims-Based Retrospective Cohort Study from Taiwan and the USA
title_sort serious infection rates among patients with select autoimmune conditions: a claims-based retrospective cohort study from taiwan and the usa
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10011274/
https://www.ncbi.nlm.nih.gov/pubmed/36572758
http://dx.doi.org/10.1007/s40744-022-00525-x
work_keys_str_mv AT huangwennan seriousinfectionratesamongpatientswithselectautoimmuneconditionsaclaimsbasedretrospectivecohortstudyfromtaiwanandtheusa
AT chuochingyi seriousinfectionratesamongpatientswithselectautoimmuneconditionsaclaimsbasedretrospectivecohortstudyfromtaiwanandtheusa
AT linchingheng seriousinfectionratesamongpatientswithselectautoimmuneconditionsaclaimsbasedretrospectivecohortstudyfromtaiwanandtheusa
AT chenyiming seriousinfectionratesamongpatientswithselectautoimmuneconditionsaclaimsbasedretrospectivecohortstudyfromtaiwanandtheusa
AT linweiszu seriousinfectionratesamongpatientswithselectautoimmuneconditionsaclaimsbasedretrospectivecohortstudyfromtaiwanandtheusa
AT tuckwellkatie seriousinfectionratesamongpatientswithselectautoimmuneconditionsaclaimsbasedretrospectivecohortstudyfromtaiwanandtheusa
AT jonesnicholass seriousinfectionratesamongpatientswithselectautoimmuneconditionsaclaimsbasedretrospectivecohortstudyfromtaiwanandtheusa
AT galanterjoshua seriousinfectionratesamongpatientswithselectautoimmuneconditionsaclaimsbasedretrospectivecohortstudyfromtaiwanandtheusa
AT lindsaylisa seriousinfectionratesamongpatientswithselectautoimmuneconditionsaclaimsbasedretrospectivecohortstudyfromtaiwanandtheusa